SS.SR-(D7Mco19-D7Mco7)/Jr |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 29 days) then controlled sodium content diet (4 %) (between 40 and 41 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
heart left ventricle end-diastolic diameter |
male |
109 days-112 days |
4 |
8.6 |
mm |
0.4 |
0.8 |
transthoracic echocardiography |
0 |
|
0 |
|
|
65744 |
283 |
SS/JrSeac |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (8 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle end-diastolic diameter |
not specified |
77 days
| 5 |
5.26 |
mm |
0.49 |
1.1 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68580 |
733 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle end-diastolic diameter |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
252 days
| 6 |
7.83 |
mm |
0.3 |
0.73 |
echocardiography |
0.0 |
|
0 |
|
|
99581 |
2319 |
SR |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (6 %) (between 56 and 70 days) then pentobarbital (50 mg/kg) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
heart left ventricle end-diastolic diameter |
male |
98 days-132 days |
7 |
5.8 |
mm |
0.42 |
1.1 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
103370 |
2804 |
SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
0 days
| 6 |
7.1 |
mm |
0.2 |
0.49 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
2 |
days |
|
98847 |
2160 |
SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
0 days
| 6 |
7.1 |
mm |
0.2 |
0.49 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
5 |
days |
|
98849 |
2160 |
SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic diameter |
vehicle control condition |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
84 days
| 7 |
7.52 |
mm |
0.32 |
0.85 |
echocardiography |
0.0 |
|
0 |
|
|
99768 |
2319 |
SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic diameter |
gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
84 days
| 6 |
8.33 |
mm |
0.4 |
0.98 |
echocardiography |
0.0 |
|
0 |
|
|
99769 |
2319 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle end-diastolic diameter |
bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days) |
Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. |
heart left ventricle end-diastolic diameter |
female |
91 days
| 8 |
7.2 |
mm |
0.14 |
0.4 |
echocardiography |
0.0 |
ovariectomy |
42 |
days |
|
101717 |
2622 |
WKY |
heart left ventricle end-diastolic diameter |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266 days-280 days |
16 |
10.8 |
mm |
0.3 |
1.2 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100307 |
2460 |
SS-Adora2bem2Mcwi |
heart left ventricle end-diastolic diameter |
isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
147 days
| 10 |
7.68 |
mm |
0.12 |
0.38 |
transthoracic echocardiography |
0.0 |
|
0 |
|
should be inner diameter |
105799 |
3023 |
SS/JrHsdMcwi |
heart left ventricle end-diastolic diameter |
angiotensin II (200 ng/kg/min) (for 14 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
63 days-70 days |
5 |
6.63 |
mm |
0.37 |
0.83 |
transthoracic echocardiography |
0.0 |
|
0 |
|
should be inner diameter |
105822 |
3023 |
SS.LEW-(D16Chm36-D16Mit2)/Ayd |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 18 |
7.75 |
mm |
0.17 |
0.74 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68269 |
542 |
SR |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
heart left ventricle end-diastolic diameter |
male |
126 days
| 6 |
7.3 |
mm |
0.24 |
0.6 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
103311 |
2803 |
SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
72 days
| 5 |
7.0 |
mm |
0.1 |
0.22 |
echocardiography |
0.0 |
sham ACF |
2 |
days |
|
99341 |
2278 |
SD |
heart left ventricle end-diastolic diameter |
artificial aortocaval fistula (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 8 |
10.6 |
mm |
0.3 |
0.85 |
echocardiography |
0.0 |
ACF |
28 |
days |
|
99344 |
2278 |
SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic diameter |
vehicle control condition |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
168 days
| 7 |
8.68 |
mm |
0.33 |
0.87 |
echocardiography |
0.0 |
|
0 |
|
|
99770 |
2319 |
WKY |
heart left ventricle end-diastolic diameter |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266 days-280 days |
32 |
10.6 |
mm |
0.3 |
1.7 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100308 |
2460 |
SS/JrSeac |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.3 %) (for 84 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle end-diastolic diameter |
not specified |
126 days
| 5 |
6.3 |
mm |
0.25 |
0.57 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68581 |
733 |
SS.LEW-(D18Chm41-D18Rat92)/Ayd |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 8 |
7.36 |
mm |
0.1 |
0.27 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68268 |
542 |
SS/NEisSlc |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then vehicle control condition (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
heart left ventricle end-diastolic diameter |
male |
126 days
| 8 |
8.7 |
mm |
0.3 |
0.85 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
102320 |
2684 |
SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic diameter |
control condition (for 28 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
28 days
| 7 |
5.3 |
mm |
0.49 |
1.3 |
echocardiography |
0.0 |
|
0 |
|
|
99574 |
2319 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle end-diastolic diameter |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
168 days
| 5 |
8.48 |
mm |
0.08 |
0.18 |
echocardiography |
0.0 |
|
0 |
|
|
99579 |
2319 |
SR |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (6 %) (between 35 and 49 days) then pentobarbital (50 mg/kg) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
heart left ventricle end-diastolic diameter |
male |
77 days-91 days |
7 |
6.0 |
mm |
0.26 |
0.7 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
103369 |
2804 |
SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic diameter |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
168 days
| 5 |
8.84 |
mm |
0.09 |
0.2 |
echocardiography |
0.0 |
|
0 |
|
|
99580 |
2319 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle end-diastolic diameter |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 7 |
7.58 |
mm |
0.2 |
0.53 |
echocardiography |
0.0 |
|
0 |
|
|
101789 |
2641 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (for 21 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 4 |
8.75 |
mm |
0.66 |
1.32 |
echocardiography |
0.0 |
|
0 |
|
|
99712 |
2319 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle end-diastolic diameter |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 13 |
8.56 |
mm |
0.08 |
0.29 |
echocardiography |
0.0 |
|
0 |
|
|
101996 |
2644 |
SD |
heart left ventricle end-diastolic diameter |
artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
0 days
| 6 |
7.4 |
mm |
0.3 |
0.73 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
360 |
min |
|
98842 |
2160 |
SD |
heart left ventricle end-diastolic diameter |
artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
0 days
| 6 |
7.8 |
mm |
0.4 |
0.98 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
720 |
min |
|
98844 |
2160 |
SD |
heart left ventricle end-diastolic diameter |
artificial aortocaval fistula (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
175 days
| 10 |
11.6 |
mm |
0.4 |
1.26 |
echocardiography |
0.0 |
ACF |
105 |
days |
|
99238 |
2278 |
SD |
heart left ventricle end-diastolic diameter |
artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 8 |
10.2 |
mm |
0.2 |
0.57 |
echocardiography |
0.0 |
ACF |
28 |
days |
|
99346 |
2278 |
WKY |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238 days-252 days |
12 |
8.3 |
mm |
0.2 |
0.69 |
echocardiography |
0.0 |
lad occlusion sham |
196 |
days |
|
100339 |
2460 |
SS/Jr |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 40 |
7.18 |
mm |
0.09 |
0.57 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68266 |
542 |
SS/JrHsdMcwi |
heart left ventricle end-diastolic diameter |
isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
147 days
| 10 |
7.8 |
mm |
0.14 |
0.44 |
transthoracic echocardiography |
0.0 |
|
0 |
|
should be inner diameter |
105798 |
3023 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle end-diastolic diameter |
control condition (for 252 days) |
Holditch SJ, et al., Sci Rep. 2016 May 10;6:25623. doi: 10.1038/srep25623. |
heart left ventricle end-diastolic diameter |
female |
252 days
| 4 |
7.28 |
mm |
0.11 |
0.22 |
echocardiography |
0.0 |
|
0 |
|
|
101643 |
2621 |
SS.SR-(D3Arb14-D3Mco36)/Mco |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 29 days) then controlled sodium content diet (4 %) (between 40 and 41 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
heart left ventricle end-diastolic diameter |
male |
109 days-112 days |
7 |
7.3 |
mm |
0.4 |
1.06 |
transthoracic echocardiography |
0 |
|
0 |
|
|
65742 |
283 |
SS.LEW-(D3Rat52-D3Chm57)/Ayd |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 8 |
6.94 |
mm |
0.23 |
0.65 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68272 |
542 |
SR/NEisSlc |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
heart left ventricle end-diastolic diameter |
male |
126 days
| 8 |
6.5 |
mm |
0.1 |
0.28 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
102319 |
2684 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle end-diastolic diameter |
control condition (for 28 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
28 days
| 5 |
5.7 |
mm |
0.36 |
0.8 |
echocardiography |
0.0 |
|
0 |
|
|
99573 |
2319 |
SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic diameter |
control condition (for 56 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
56 days
| 6 |
8.18 |
mm |
0.35 |
0.86 |
echocardiography |
0.0 |
|
0 |
|
|
99576 |
2319 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle end-diastolic diameter |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 12 |
8.05 |
mm |
0.07 |
0.24 |
echocardiography |
0.0 |
|
0 |
|
|
101790 |
2641 |
SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
0 days
| 6 |
7.2 |
mm |
0.3 |
0.73 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
360 |
min |
|
98843 |
2160 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle end-diastolic diameter |
bilateral ovariectomy (for 42 days) then 17 beta-estradiol (0.5 mg) (for 35 days) |
Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. |
heart left ventricle end-diastolic diameter |
female |
91 days
| 7 |
7.1 |
mm |
0.12 |
0.32 |
echocardiography |
0.0 |
ovariectomy |
42 |
days |
|
101718 |
2622 |
SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 8 |
7.0 |
mm |
0.2 |
0.57 |
echocardiography |
0.0 |
sham ACF |
28 |
days |
|
99235 |
2278 |
SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
175 days
| 10 |
9.0 |
mm |
0.1 |
0.32 |
echocardiography |
0.0 |
sham ACF |
105 |
days |
|
99237 |
2278 |
SD |
heart left ventricle end-diastolic diameter |
artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
72 days
| 5 |
8.0 |
mm |
0.1 |
0.22 |
echocardiography |
0.0 |
ACF |
2 |
days |
|
99342 |
2278 |
SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 7 |
7.7 |
mm |
0.2 |
0.53 |
echocardiography |
0.0 |
sham ACF |
28 |
days |
|
99343 |
2278 |
SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 7 |
7.6 |
mm |
0.1 |
0.26 |
echocardiography |
0.0 |
sham ACF |
28 |
days |
|
99345 |
2278 |
WKY |
heart left ventricle end-diastolic diameter |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238 days-252 days |
20 |
10.6 |
mm |
0.2 |
0.89 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100340 |
2460 |
SS-Adora2bem2Mcwi |
heart left ventricle end-diastolic diameter |
isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
49 days-56 days |
7 |
7.12 |
mm |
0.22 |
0.58 |
transthoracic echocardiography |
0.0 |
|
0 |
|
should be inner diameter |
105821 |
3023 |
SS-Adora2bem2Mcwi |
heart left ventricle end-diastolic diameter |
angiotensin II (200 ng/kg/min) (for 14 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
63 days-70 days |
7 |
6.73 |
mm |
0.18 |
0.48 |
transthoracic echocardiography |
0.0 |
|
0 |
|
should be inner diameter |
105823 |
3023 |
SS/JrHsdMcwi |
heart left ventricle end-diastolic diameter |
angiotensin II (200 ng/kg/min) (for 28 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
77 days-84 days |
5 |
7.15 |
mm |
0.34 |
0.76 |
transthoracic echocardiography |
0.0 |
|
0 |
|
should be inner diameter |
105824 |
3023 |
SS.LEW-(D10Got112-Igfbp4)/Ayd |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 5 |
7.36 |
mm |
0.3 |
0.67 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68271 |
542 |
WKY |
heart left ventricle end-diastolic diameter |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238 days-252 days |
30 |
10.6 |
mm |
0.1 |
0.55 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100341 |
2460 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle end-diastolic diameter |
vehicle control condition (0.5 %) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 13 |
8.27 |
mm |
0.13 |
0.47 |
echocardiography |
0.0 |
|
0 |
|
|
101995 |
2644 |
SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
72 days
| 5 |
6.9 |
mm |
0.2 |
0.45 |
echocardiography |
0.0 |
sham ACF |
2 |
days |
|
99339 |
2278 |
SS/Jr |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 29 days) then controlled sodium content diet (4 %) (between 40 and 41 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
heart left ventricle end-diastolic diameter |
male |
109 days-112 days |
6 |
7.4 |
mm |
0.4 |
0.98 |
transthoracic echocardiography |
0 |
|
0 |
|
|
65741 |
283 |
LEW |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 14 |
7.16 |
mm |
0.25 |
0.93 |
transthoracic echocardiography |
0.0 |
|
0 |
|
heart left ventricle anterior wall thickness |
68265 |
542 |
SS.LEW-(D16Rat112-D16Chm60)/Ayd |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 14 |
7.51 |
mm |
0.11 |
0.42 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68270 |
542 |
SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic diameter |
control condition (for 252 days) |
Holditch SJ, et al., Sci Rep. 2016 May 10;6:25623. doi: 10.1038/srep25623. |
heart left ventricle end-diastolic diameter |
female |
252 days
| 5 |
7.81 |
mm |
0.06 |
0.13 |
echocardiography |
0.0 |
|
0 |
|
|
101644 |
2621 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle end-diastolic diameter |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
84 days
| 6 |
7.53 |
mm |
0.07 |
0.17 |
echocardiography |
0.0 |
|
0 |
|
|
99577 |
2319 |
SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic diameter |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
84 days
| 10 |
7.52 |
mm |
0.32 |
1.01 |
echocardiography |
0.0 |
|
0 |
|
|
99578 |
2319 |
SR |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
heart left ventricle end-diastolic diameter |
male |
84 days
| 6 |
6.7 |
mm |
0.33 |
0.8 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
103309 |
2803 |
SR |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (6 %) (between 21 and 28 days) then pentobarbital (50 mg/kg) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
heart left ventricle end-diastolic diameter |
male |
63 days-70 days |
7 |
5.7 |
mm |
0.45 |
1.2 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
103368 |
2804 |
SS |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (6 %) (between 56 and 70 days) then pentobarbital (50 mg/kg) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
heart left ventricle end-diastolic diameter |
male |
98 days-132 days |
7 |
5.2 |
mm |
0.26 |
0.7 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
103373 |
2804 |
SS.ZUC-Leprfa+/+/Slc |
heart left ventricle end-diastolic diameter |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 8 |
8.09 |
mm |
0.22 |
0.62 |
echocardiography |
0.0 |
|
0 |
|
|
101787 |
2641 |
SD |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
0 days
| 6 |
7.3 |
mm |
0.3 |
0.73 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
720 |
min |
|
98845 |
2160 |
SD |
heart left ventricle end-diastolic diameter |
artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
0 days
| 6 |
8.1 |
mm |
0.2 |
0.49 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
2 |
days |
|
98846 |
2160 |
SD |
heart left ventricle end-diastolic diameter |
artificial aortocaval fistula (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
72 days
| 5 |
8.2 |
mm |
0.2 |
0.45 |
echocardiography |
0.0 |
ACF |
2 |
days |
|
99340 |
2278 |
SS/JrHsdMcwi |
heart left ventricle end-diastolic diameter |
isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
49 days-56 days |
5 |
6.99 |
mm |
0.16 |
0.36 |
transthoracic echocardiography |
0.0 |
|
0 |
|
should be inner diameter |
105820 |
3023 |
SS-Adora2bem2Mcwi |
heart left ventricle end-diastolic diameter |
angiotensin II (200 ng/kg/min) (for 28 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
heart left ventricle end-diastolic diameter |
male |
77 days-84 days |
7 |
7.06 |
mm |
0.22 |
0.58 |
transthoracic echocardiography |
0.0 |
|
0 |
|
should be inner diameter |
105825 |
3023 |
SS/JrSeac |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.3 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle end-diastolic diameter |
not specified |
77 days
| 5 |
5.82 |
mm |
0.3 |
0.66 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68579 |
733 |
SS/JrSeac |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (8 %) (for 84 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle end-diastolic diameter |
not specified |
126 days
| 5 |
8.9 |
mm |
0.93 |
2.07 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68582 |
733 |
SS |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
heart left ventricle end-diastolic diameter |
male |
84 days
| 7 |
6.4 |
mm |
0.34 |
0.9 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
103308 |
2803 |
SS.LEW-(D18Rat29-D18Rat55)/Ayd |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 11 |
7.41 |
mm |
0.14 |
0.46 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
68267 |
542 |
SS/NEisSlc |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
heart left ventricle end-diastolic diameter |
male |
126 days
| 8 |
7.0 |
mm |
0.2 |
0.57 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
102321 |
2684 |
SS |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
heart left ventricle end-diastolic diameter |
male |
126 days
| 6 |
8.7 |
mm |
0.12 |
0.3 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
103310 |
2803 |
SS |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (6 %) (between 21 and 28 days) then pentobarbital (50 mg/kg) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
heart left ventricle end-diastolic diameter |
male |
63 days-70 days |
7 |
6.1 |
mm |
0.42 |
1.1 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
103371 |
2804 |
SS |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (6 %) (between 35 and 49 days) then pentobarbital (50 mg/kg) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
heart left ventricle end-diastolic diameter |
male |
77 days-91 days |
7 |
5.7 |
mm |
0.42 |
1.1 |
transthoracic echocardiography |
0.0 |
|
0 |
|
|
103372 |
2804 |
SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic diameter |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
252 days
| 5 |
8.88 |
mm |
0.22 |
0.49 |
echocardiography |
0.0 |
|
0 |
|
|
99582 |
2319 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle end-diastolic diameter |
control condition (for 56 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
56 days
| 5 |
8.11 |
mm |
0.35 |
0.78 |
echocardiography |
0.0 |
|
0 |
|
|
99575 |
2319 |
SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (for 21 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 4 |
8.17 |
mm |
0.32 |
0.64 |
echocardiography |
0.0 |
|
0 |
|
|
99713 |
2319 |
SS.ZUC-Leprfa+/+/Slc |
heart left ventricle end-diastolic diameter |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 10 |
7.65 |
mm |
0.12 |
0.38 |
echocardiography |
0.0 |
|
0 |
|
|
101788 |
2641 |
SD |
heart left ventricle end-diastolic diameter |
artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle end-diastolic diameter |
male |
0 days
| 6 |
7.9 |
mm |
0.2 |
0.49 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
5 |
days |
|
98848 |
2160 |
SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic diameter |
gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
168 days
| 6 |
8.33 |
mm |
0.64 |
1.57 |
echocardiography |
0.0 |
|
0 |
|
|
99771 |
2319 |
SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic diameter |
vehicle control condition |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
252 days
| 7 |
7.99 |
mm |
0.62 |
1.64 |
echocardiography |
0.0 |
|
0 |
|
|
99772 |
2319 |
SS.ZUC-Leprfa+/+/Slc |
heart left ventricle end-diastolic diameter |
bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days) |
Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. |
heart left ventricle end-diastolic diameter |
female |
91 days
| 9 |
7.21 |
mm |
0.21 |
0.63 |
echocardiography |
0.0 |
ovariectomy |
42 |
days |
|
101715 |
2622 |
SS.ZUC-Leprfa+/+/Slc |
heart left ventricle end-diastolic diameter |
bilateral ovariectomy (for 42 days) then 17 beta-estradiol (0.5 mg) (for 35 days) |
Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. |
heart left ventricle end-diastolic diameter |
female |
91 days
| 12 |
6.5 |
mm |
0.17 |
0.59 |
echocardiography |
0.0 |
ovariectomy |
42 |
days |
|
101716 |
2622 |
SD |
heart left ventricle end-diastolic diameter |
artificial aortocaval fistula (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 8 |
10.1 |
mm |
0.3 |
0.85 |
echocardiography |
0.0 |
ACF |
28 |
days |
|
99236 |
2278 |
SS.ZUC-Leprfa-/-/Slc |
heart left ventricle end-diastolic diameter |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 13 |
8.43 |
mm |
0.11 |
0.4 |
echocardiography |
0.0 |
|
0 |
|
|
101997 |
2644 |
SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 29 days) then controlled sodium content diet (4 %) (between 40 and 41 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
heart left ventricle end-diastolic diameter |
male |
109 days-112 days |
7 |
6.9 |
mm |
0.2 |
0.53 |
transthoracic echocardiography |
0 |
|
0 |
|
|
65743 |
283 |
WKY |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266 days-280 days |
5 |
7.9 |
mm |
0.2 |
0.45 |
echocardiography |
0.0 |
lad occlusion sham |
210 |
days |
|
100306 |
2460 |
SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic diameter |
gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
252 days
| 6 |
8.52 |
mm |
0.51 |
1.25 |
echocardiography |
0.0 |
|
0 |
|
|
99773 |
2319 |